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Abstract
Background: Oxytocin receptor (OXTR) gene variants have been shown to affect the prevalence of preterm birth, mode
of delivery and oxytocin (OXT) requirements for labor induction and augmentation. We hypothesized that this might be
associated with different myometrium responses to oxytocin. Our aim was to investigate the influence of a selection of
eight OXTR gene single nucleotide variants on oxytocin-induced stimulation of human myometrium contractility in vitro.
Methods: Human myometrium biopsies were collected during elective cesarean sections at term, if patients had given
informed consent. Myometrial strips were submerged under tension in an organ bath and allowed to contract; the
remaining material was stored at − 80 °C for further determination of relevant genetics and mRNA level. The area under
the curve (AUC) of all contractions taking place in the absence of OXT and of those occurring upon OXT addition (for
30min each) was measured. OXT stimulation, defined as the ratio between AUC measurements after OXT addition and
those in the absence of OXT was calculated for each strip. TaqMan™ Assays were used to detect the allele distribution
of the eight OXTR variants and to determine the relative amounts of OXTR-mRNA in the samples. For each variant,
oxytocin stimulation of contractility was compared between samples homozygous for the reference allele (reference
group) and samples with at least one variant allele (variant group) by linear regression.
Results: Sixty samples were included in the present study. For rs1042778, rs11706648, rs4686301, rs53576, rs237895, and
rs237902, OXT stimulation was similar in the reference and in the variant groups. However, the values of OXT stimulation
differed significantly between the reference and the variant groups for rs4686302 (3.1 vs. 4.1 times; p = 0.022)
and rs237888 (3.2 vs. 5.5 times; p = 0.001). No significant differences between the levels of OXTR-mRNA in the
various reference and corresponding variant groups were detected.
Conclusions: Patients with variant alleles of rs237888 and/or rs4686302 may be more sensitive to oxytocin stimulation,
explaining why these sequence variants have been associated with lower cesarean section
prevalence and premature birth, respectively.
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Background
Oxytocin (OXT) is a peptide of nine amino acids that
exerts various effects in the human body, triggering both
central and peripheral receptors (see e.g. [1–4]). Endogen-
ous OXT plays important roles in the labor process, lacta-
tion and maternal behavior after birth. During labor,
uterus contractions are triggered through the binding of
endogenous OXT to its receptor in myometrium cells. If
required, uterine activity can be stimulated with synthetic
OXT [5] to induce or augment labor, to support placental
delivery or to prevent postpartum hemorrhage. Towards
the end of pregnancy [6] and during treatment with syn-
thetic OXT [7], expression of oxytocin receptor (OXTR)
in myometrium cells increases. Changes in OXTR expres-
sion, but also the existence of genetically variant forms of
this receptor are likely to affect sensitivity towards OXT
(and other OXTR binding medications), and to contribute
to the variety of patient responses that are observed in
clinical practice.
Previous experimental work has shown that a few rare
single-nucleotide variants of OXTR might affect the
binding of OXT to this seven-transmembrane-helix re-
ceptor and possibly affect OXT-mediated signal trans-
duction [8]. Moreover, an association between a few
common substitution OXTR variants and the prevalence
of preterm birth has been suggested [8]. Other studies
revealed that a combination of three common minor
allelic variants from the OXTR can increase preterm
birth risk [9], and that the minor allele of the common
rs53576 variant is associated with a long transition to
active labor [10]. Finally, there are some indications that
OXTRsingle-nucleotide variants may affect the response
to OXT-treatment with regard to labor induction and
augmentation, mode of delivery and prevalence of pre-
term birth [11].
We hypothesized that at least some of the influences
of OXTR variants on clinically-relevant outcomes occur
through changes in OXT-mediated cell signaling. Our
objective was to investigate whether some common
OXTRsingle-nucleotide sequence variants that have
previously been shown to affect perinatal outcomes are
associated with different oxytocin-induced stimulation of
human myometrium contractility in vitro.
Methods
Samples
In two original in vitro studies performed at the Univer-
sity Hospital of Zurich (see [12, 13]), the effects of vari-
ous tocolytic agents on term myometrium contractility
were compared. In these studies, contractility of myome-
trium strips was often measured in the absence and/or
in the presence of OXT, and, when enough material was
available, tissue samples were shock frozen with liquid
nitrogen and stored at − 80 °C for further determination
of relevant genetics and mRNA level. Patients were asked
to donate a myometrium sample if they were going to
undergo an elective cesarean section at term, had a single-
ton pregnancy, had not received tocolytics during the last
2 weeks, had had no previous cesarean section, had no pre-
mature rupture of membranes, had no amniotic infection
syndrome, and had no preeclampsia or HIV-Infection.
During surgery, a myometrium sample of about 5 g was re-
moved from the patient’s uterus by the physician in charge
and placed immediately in ice-cold Ringer’s solution. Part
of the sample was further processed for the contractility
experiments, the remaining material was cut in pieces of
approximately 60mg, shock frozen in liquid nitrogen and
kept at − 80 °C until DNA and RNA extraction. For the
present study, samples were included if contractility data in
both the absence and presence of OXT to stimulate con-
tractions of maximal strength (either 1 U/mL or 40U/mL)
was available for at least one strip and enough DNA and
RNA could be extracted. These conditions were fulfilled by
60 out of 133 possible samples.
Oxytocin-stimulated myometrium contractility
Part of the myometrium sample was cut in longitudinal
strips of about 15 × 2 × 1mm. These strips were mounted
on the myograph (Myograph DMT800MS, Muscle Strip
Myograph System, DMT, Denmark; provided by ADIn-
struments GmbH, Spechbach, Germany) between two
clamps in a chamber filled with 6mL of Krebs solution
(118mM NaCl, 24.9mM NaHCO3, 4.7 mM KCl, 1.24mM
KH2PO4, 2.48mM CaCl2, 1.21mM MgSO4, 10mM glu-
cose, 0.034mM EDTA, pH = 7.4). The temperature was
regulated to 37 °C and the medium was enriched with a
gas mixture (95% O2 and 5% CO2, Pan Gas, Dagmarsellen,
Switzerland). Contraction data was transferred to a PC for
analysis with the software Labchart Pro 8.0.6 (ADInstru-
ments GmbH, Spechbach, Germany) via a transducer
(PowerLab 4/30, ADInstruments GmbH, Spechbach,
Germany). The strength (measured in grams, g) of regular
spontaneous myometrium contractions (i.e. in the absence
of OXT) and of contractions occurring upon OXT
addition were recorded for 30min each. The area under
the curve (AUC, g x s) of all contractions taking place in
the absence of OXT and of all contractions occurring
upon OXT addition (for 30min each) was measured and
taken as an indicator of contractility. OXT stimulation,
defined as the ratio between AUC measurements after
OXT addition and those in the absence of OXT was
calculated for each strip. OXT was used at concentrations
known to maximally stimulate contractility in vitro (1 and
40U/mL, depending on the original study).
DNA and RNA extraction
All protocols were performed according to the manufac-
turers’ instructions. Frozen myometrium tissue was
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removed from the − 80 °C freezer and placed immedi-
ately in liquid nitrogen to prevent tissue thawing. A
small piece of frozen myometrium tissue (ca. 60 mg) was
cut and ground to a fine powder by using a cold mortar
and pestle. For at least 2 h before starting this procedure,
the mortar and pestle were stored at − 80 °C; all instru-
ments and 1.5 mL Eppendorf tubes used were placed in
liquid nitrogen before starting. While the myometrium
tissue was being ground, small amounts of liquid nitro-
gen were added to prevent thawing of the tissue. About
40 mg of the ground powder was transferred to a 1.5 mL
Eppendorf tube that was in the liquid nitrogen. The tube
with the powder was placed in liquid nitrogen until the
other samples were prepared. The remaining tissue was
stored again at − 80 °C. DNA and RNA were extracted
with the AllPrep DNA/RNA/Protein Kit (Qiagen) and
were quantified using a Nanodrop™1000 (Thermo Scien-
tific, USA).
Determination of a selection of OXTR single-nucleotide
sequence variants
TaqMan™ Assays (Applied Biosystems, Forster City, CA,
USA) were used to detect the allele distribution of eight
common OXTRsingle-nucleotide sequence variants previ-
ously shown to be associated with a relevant perinatal out-
come (see additional annotations and functional data
extracted from SNPnexus http://www.snp-nexus.org/ in
Additional file 1: Table S1). Genotyping was performed on
DNA extracted as described above, using 384 well plates
sealed with an optic adhesive film in a ViiA 7 Real-Time
PCR System (Applied Biosystem, Forster City, CA, USA).
The investigated variants (and assays ID) were: rs1042778
(C__7622140_30), rs11706648 (C__3290321_10), rs237888
(C__3290324_10), rs4686301 (C__3290326_10), rs53576
(C__3290335_20), rs237895 (C__1750495_10), rs237902
(C__3290345_30) and rs4686302 (C__3290346_20).
Quantification of mRNA
To compare the relative amounts of OXTR-mRNA in
the various myometrium samples, cDNA was first syn-
thesized from RNA (QuantiTec® reverse transcription
Kit, Qiagen, CA, USA) and subsequently submitted to
quantitative real-time PCR (ViiA 7 Real-Time PCR
System; Applied Biosystems, Forster City, CA, USA).
The cDNA corresponding to the OXTR-mRNA (assay
Hs00168573_m1), as well as to the reference genes GAPDH-
mRNA (Hs02786624_g1), 18S rRNA (Hs03003631_g1) and
EEF1A1-mRNA (Hs00265885_g1) were determined. Cycle
threshold (CT) values were determined and mean PCR
efficiencies were calculated using the ‘LinRegPCR’ pro-
gram [14]; the latter were in a range between 80 and
95%. Quantification of OXTR-mRNA levels normalized
to GAPDH-mRNA, 18S rRNA and EEF1A1-mRNA was
carried out using ‘Biogazelle qBASE plus’ software
(Biogazelle, Zwijnaarde, Belgium) [15], thus taking into
account the specific PCR efficiency for each reaction.
This software enables normalization to more than one
reference gene, is able to take into account gene-
specific PCR efficiency and also employs signals from
inter-run calibration to minimize run-to-run variation,
which distinguishes it from the ΔCt method. The data
are expressed as Calibrated Normalized Relative Quan-
tities (CNRQ).
Data analysis
Throughout this manuscript the genetic nomenclature
according to recommendations of Human Genome Vari-
ation Society (HGVS) and American College of Medical
Genetics and Genomics (ACMGG) is used [16, 17].
For each sequence variant, samples were divided into
two groups according to genotype; i.e. whether (1) they
were homozygous for the reference allele (reference
group) or (2) possessed at least one variant allele (variant
group). In each case, reference and variant group were
compared by linear regression. The OXT concentration
used in the two original studies was considered a poten-
tial covariate in the association between reference group
and variant group; confounding was evaluated by adding
this variable to the linear regression model and looking
at the change of the regression coefficients. Data was an-
alyzed with IBM® SPSS® Statistics Version 23 and is
shown as mean ± S.D., unless otherwise indicated. Two-
tailedp-values < 0.05 were considered statistically signifi-
cant. Link disequilibrium (LD) was determined using
LDlink 3.0. (https://ldlink.nci.nih.gov/; see Additional file 2:
Table S2 for the LD of all variants studied). Hardy-
Weinberg Equilibrium was tested for each of the variants
using gene calculator https://www.genecalculators.net/asso-
ciatorrr-cc.html. P-value < 0.05 indicated disequilibrium of
the genotypes (results see Additional file 3: Table S3).
Results
As was to be expected from the criterion of including
samples collected during the two original studies, all
myometrium samples considered in the present analysis
(n = 60) were capable of contracting spontaneously
in vitro and were able to contract long enough for spon-
taneous contractility characterization as well as for
contractility measurement upon addition of OXT to the
myograph chamber. Therefore, OXT stimulation could
be calculated in all cases. Its average was 3.4 times the
value of the initial, spontaneous contractility (S.D. 1.5,
median 3.0, minimum 0.8, and maximum 10.5). The
main characteristics of the patients who donated the
myometrium biopsies used in the present functional
study are summarized in Table 1.
In Table 2, the selected OXTRsingle-nucleotide se-
quence variants are briefly described, together with their
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minor allele frequency (MAF)-values in the currently
studied population, their MAF-values for the European
population and previously described influence on
perinatal outcomes (for further information on the vari-
ants see Additional file 1: Table S1). The number of
samples with each one of the three possible allele combi-
nations of each single-nucleotide variant are depicted in
Additional file 3: Table S3. Given the very low number
of samples homozygous for the variant alleles, samples
were divided in two categories only for further calcula-
tions on each variant: the reference group, containing all
samples with no variant allele and the variant group, in
which all samples had at least one variant allele.
OXT stimulation of myometrium contractility in the
reference and variant allele groups of the selected OXTR
sequence variants were compared (see Table 3). In most
cases, OXT stimulation was similar in the two groups
compared. However, the values of OXT stimulation dif-
fered significantly between the reference and the variant
groups for rs4686302 (3.1 vs. 4.1 times; p = 0.022) and
rs237888 (3.2 vs. 5.5 times; p = 0.001).
During the original studies performed on myometrial
contractility, two different concentrations of OXT were
used (1 U/mL or 40 U/mL) to stimulate contractions of
maximal strength. To verify whether these different con-
centrations had an impact on the results, OXT concen-
tration was added as a co-variate to the linear regression
model used to compare reference and variant groups
(multivariate model). Comparison of the beta coefficients
with those obtained in the univariate linear regression
model showed that, both in the case of rs237888 and of
rs4686302, the differences between reference and variant
groups remained significant (p = 0.001 and p = 0.028,
respectively).
We have considered the possibility that rs237888 and
rs4686302 could co-exist in some samples. Only one
sample had both allele variants rs237888 and rs4686302;
interestingly, this was the sample with the highest OXT
stimulation. To find out whether rs237888 and
rs4686302 are in LD, a linkage disequilibrium analysis
within the European population was performed. This
analysis revealed that no disequilibrium between
rs237888 and rs4686302 exists ((EUR population R2 =
0.003, D’ = 0.577; Additional file 2: Table S2). In some of
the sequence variants studied, high LDs were detected,
e.g. rs4686301 and rs11706648 (EUR population R2 =
0.884, D’ = 0.967), and low LD between rs237895 and
rs53576 (EUR population R2 = 0.718, D’ = 0.962). How-
ever, most of the sequence variants studied had low to
no LD (see Additional file 2: Table S2).
The relative levels of OXTR-mRNA varied among the
study population. Since the expression level of OXTR is
likely to affect myometrium contractility and sequence
variants might affect OXTR expression, the levels of
OXTR-mRNA in the various reference and variant
groups were compared. For each case, no significant
differences between the levels of OXTR-mRNA in the
reference group and the variant group were detected (s.
Additional file 4: Table S4).
Discussion
Main findings
Our data reveals that two OXTR sequence variants
previously shown to be associated with birth-related out-
comes – rs237888 and rs4686302 – significantly affect
the OXT-induced stimulation of myometrium contract-
ility in vitro. In other words, the increase in contraction
force upon OXT stimulation in the groups of samples
with these OXTR allele variants was higher relative to
the reference groups. Other sequence variants previously
shown to be associated with birth-related outcomes –
rs1042778, rs11706648, rs4686301, rs53576, rs237895,
and rs237902 – did not seem to affect OXT stimulation
of contractility under our experimental conditions.
Strengths and limitations
In this functional in vitro study, the effects on myo-
metrium response to OXT were observed in an assay
that closely reflects the biological environment. More-
over, the myograph-setup allows working under de-
fined conditions. These aspects can be seen as major
strengths of our study, which complements well pre-
vious work based on clinical and epidemiological data.
Table 1 Characteristics of the patients who donated the
myometrium biopsies analyzed in the present work (n = 60)
Characteristic Values a
Age (years) 34.0 ± 5.1
BMI (before pregnancy) 26.1 ± 8.5b
Gravidity (number) 2.0 ± 1.2
Parity (number) 1.4 ± 0.6
Comorbidities
hypothyroidism 10
gestational diabetes 10c
obesity (BMI≥ 30) 6
overweight (BMI≥ 25) 3
gestational hypertension 3
hyperthyroidism 1
uterine atony 1
osteoporosis 1
anorexia 1
Gestational age (weeks) 38.3 ± 0.7
Cesarean (number) 1.0 ± 0.0
a for continuous variables given as mean ± S.D., otherwise as number
b data available for n = 26
c of these, 2 being treated with insulin
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There were also some limitations, because the data
on contractility resulted from pooling two previous
original studies designed to address other research
questions. These original studies comprised measure-
ments of contraction strength in the absence and in
the presence of only one oxytocin concentration
(dose-dependency experiments may have been more
appropriate for the present research question) in a
moderate number of samples.
Interpretation
The subgroup with at least one variant allele at rs237888 (T)
showed a higher in vitro OXT stimulation of contractility
than the corresponding reference subgroup. A previous
study showed an association between this sequence
variant and a lower risk for cesarean section among
women induced near term. This lower cesarean section
rate was associated with a lower OXT dose, lower max-
imal OXT infusion rate and lower duration of labor
induction with OXT [11]. Increased response of the
myometrium to OXT stimulation might explain the ob-
served lower cesarean rate. However, it is still unclear,
how this association can be explained in detail in terms
of molecular/cellular biology. The variant allele at
rs237888 is located in an intron, i.e. has no effect on
the protein-coding sequence. Moreover, no effect on
expression was observed (levels of mRNA were com-
parable between variant allele and reference sub-
groups). A search of the GTEx database for the impact
of this variant on the expression of OXTR was also
completed, but yielded no results (www.gtexportal.org/
home, 28.09.2018, expression quantitative trait loci,
eQTL). However, a splice variant located at rs237888 as
well as at the transcription factor binding sites (see
Regulatory Built /Ensembl; Additional file 1: Table S1)
might affect transcription and translation; this still
needs to be assessed.
The variant allele at rs4686302 (T) was previously
shown to be associated with prematurity [8]. Our data
showing an increased stimulatory effect of OXT in the
samples with this variant allele goes along with this
clinical finding as an increased stimulatory effect of
OXT during preterm labor might lead to preterm deliv-
ery. Another indication that OXT sensitivity might be
Table 2 Overview of the single-nucleotide sequence variants considered in the present work
Variant Variant-type Position (Ch37) a MAF
(Eur.) b
MAF
(study) c
Genotype (REF/MA) Association
rs1042778 3’UTR g.8794545 0.38 0.41 (G/T) maximal oxytocin infusion rate / total
oxytocin dose [11]
rs11706648 Intron g.8796547 0.32 0.28 (A/C) maximal oxytocin infusion rate [11]
rs237888 Intron g.8797095 0.06 0.05 (T/C) cesarean section [11]
rs4686301 Intron g.8798586 0.31 0.26 (C/T) maximal oxytocin infusion rate / total
oxytocin dose [11]
rs53576 Intron3 g.8804371 0.35 0.34 (G/A) time from latent to active labor [10]
rs237895 Intron g.8807423 0.41 0.42 (C/T) maximal oxytocin infusion rate [11]
rs237902 Exon 3 g.8809184 0.33 0.32 (G/A) preterm birth (suggestive) [8]
rs4686302 Exon 3 g.8809222 0.12 0.13 (C/T) preterm birth [8]
MAF Minor allele frequency
REF/MA Reference /Minor Allele gene
a position according to the genomic reference sequence NCBI Build 37.3 GRCh37.p5 assembly
b in the European population (all available EUR subgroups) according to the 1000 Genomes EUR population (SNPnexus http://snp-nexus.org)
c in the present study population
Table 3 Oxytocin stimulationa of myometrium contractility in
the various reference and variant allele groups
Oxytocin stimulation
(AUC after OXT addition/ AUC spontaneous contractility)
Reference group Variant group p-valuea
n/N Mean ± SD n/N Mean ± SD
rs1042778 21/60 3.0 ± 1.3 39/60 3.5 ± 1.6 0.192
rs11706648 29/60 3.5 ± 1.7 31/60 3.2 ± 1.3 0.435
rs237888 54/59b 3.2 ± 1.2 5/59 5.5 ± 2.9 0.001c
rs4686301 32/60 3.4 ± 1.7 28/60 3.3 ± 1.4 0.697
rs53576 25/60 3.3 ± 0.9 35/60 3.4 ± 1.9 0.974
rs237895 18/60 3.4 ± 1.0 42/60 3.3 ± 1.7 0.843
rs237902 26/60 3.8 ± 1.8 34/60 3.3 ± 1.3 0.939
rs4686302 45/60 3.1 ± 1.3 15/60 4.1 ± 2.0 0.022c
n Number of samples either in the reference group or in the variant allele
group of a given single-nucleotide sequence variant
N Number of samples for which data on a given variant are available
SD Standard deviation
a For each variant, the p-value represents the statistical significance of the
difference between reference and variant groups as calculated using
linear regression
b One sample, in which the result of the allelic determination plot was
undetermined, was excluded
c Statistically significant
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influenced by this sequence variant derives from an
American study in which several allele variants were
characterized in women requiring extreme OXT doses
[18]. rs4686302 is a common substitution variant in
exon 3 with nonsynonymous influence on the OXTR
protein. The protein corresponding to this variant has a
p.A218T amino acid substitution located in the trans-
membrane domain 5 that seems to be involved in the
important step of G-protein activation together with
the second intracellular loop and the third intracellular
loop [19]. Therefore, a small change in the tertiary
structure at this place could have consequences for G-
protein-coupled signal transduction. An in silico pre-
diction, however, revealed no functional significance of
this amino acid substitution [8]. Since this variant was
furthermore not associated with differences in the
amounts of OXTR-mRNA in the current study, the
meaning of the variant rs4686302 for OXT-induced cell
signaling remains unknown. Also, in the case of this
variant, no eQTL data were available (www.gtexportal.
org/home, 28.09.2018); nevertheless, a CpG Island is lo-
cated at the rs4686302 sequence, which might still influ-
ence expression regulation (Additional file 1: Table S1).
Labor is a complex process and numerous factors play
important roles. The existence of genetically variant
forms of OXTR are likely to influence patient responses
to medications that bind to this receptor. Concerning
treatment with synthetic OXT, clinical practice shows
that not all patients benefit equally. Patients’ response to
this medication is highly variable; some patients need
higher, others lower doses to obtain a similar effect. It is
conceivable that a screening method could enable per-
sonalized improvements in labor management. Also, the
prevention of preterm delivery, which has a major
impact on neonatal morbidity and mortality, might in
the future profit from a personalized risk assessment of
every patient. It is questionable if oxytocin-
receptorantagonists for the treatment of preterm labor
work equally well in every patient; clinical experience
and first in vitro data such as ours suggest that sub-
groups of patients with specific single-nucleotide se-
quence variants of the OXTR benefit differently from
diverse tocolytic agents. Our work, performed with myo-
metrium samples from 60 patients, suggests that patients
with rs237888 and/or rs4686302 may be more sensitive
to OXT stimulation. This might explain why patients
with these variants less often need a cesarean in the
course of labor induction with OXT [11] and were
thought to be prone to preterm labor [8], respectively].
Additional research should estimate possible clinical
benefits of introducing an rs237888 and rs4686302
screening at pregnancy begin. While doing so and given
that these two sequence variants are not in LD, it would
make sense to consider them separately.
Conclusion
Taken together, our data confirm that genetic variants of
the OXTR gene might have an impact on the birth
process and suggest that in some cases this occurs via
differences in myometrial contractility strength as
induced by OXT. Our work depicts the necessity of
starting a discussion on whether introducing an OXTR
variant screening at pregnancy begin would contribute
to reduce the prevalence of preterm deliveries and/or of
cesareans in the course of labor induction with OXT. A
screening feasibility study could contribute to address
this question. Moreover, additional basic research is
needed to clarify how exactly the various OXTR-variants
may influence contractility.
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